Apcotex Industries (APCOTEXIND) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
2 Feb, 2026Executive summary
Operating income for Q1 FY25 reached INR 237 crore, up 21% year-over-year, driven by higher volumes, improved product mix, and better price realization.
EBITDA grew 25% year-over-year to INR 32 crore, with an EBITDA margin of 9.44%.
Net profit after tax was INR 14.8 crore, up 22% year-over-year, with a net margin of 4.4%.
Audited financial results for the quarter ended June 30, 2024, were approved by the Board on July 26, 2024.
Financial statements were prepared in accordance with Indian Accounting Standards (Ind AS) and reviewed by independent auditors.
Financial highlights
Q1 FY25 operational revenue reached INR 3,366 Mn, up 21.2% year-over-year and 8.4% sequentially.
EBITDA for Q1 FY25 was INR 318 Mn, a 24.7% increase year-over-year; EBITDA margin at 9.45%.
Net profit for Q1 FY25 rose 22.3% year-over-year to INR 148 Mn; net profit margin at 4.40%.
Export volumes grew 12% and export revenue increased 18% year-over-year, now comprising 30% of total revenue.
Revenue and volumes have rebounded to pre-industry issue levels, with the highest quarterly revenue achieved.
Outlook and guidance
Margins are expected to improve gradually as industry cycles normalize and capacity utilization increases.
Management anticipates asset turnover and margins to return to historical highs as new capacities ramp up.
No immediate plans for major CapEx until margin environment improves; focus remains on R&D and incremental capacity for styrene butadiene latex.
Profit growth trajectory highlighted: +100% in FY22, +150% in FY23, +175% in FY24, and projected +200% in FY25.
Latest events from Apcotex Industries
- FY25 revenue reached INR 13,924 Mn, with ongoing capacity expansion and strong industry presence.APCOTEXIND
Investor presentation24 Feb 2026 - Q3 FY26 profit up 91% YoY, margins improved, debt reduced, and interim dividend declared.APCOTEXIND
Q3 25/262 Feb 2026 - Record revenue and export growth in H1 FY25, but margins remain under pressure.APCOTEXIND
Q2 24/2518 Jan 2026 - Record revenue and export growth, but margins compressed; interim dividend and board strengthened.APCOTEXIND
Q3 24/259 Jan 2026 - Strong H1 profit and margin growth, record exports, and major capacity expansion approved.APCOTEXIND
Q2 25/2617 Dec 2025 - FY25 revenue and exports hit records, but profit margins narrowed; Rs. 4.50 dividend proposed.APCOTEXIND
Q4 24/2518 Nov 2025 - Q1 FY26 delivered record sales, export growth, and higher margins, with a new CFO appointed.APCOTEXIND
Q1 25/2616 Nov 2025